The holiday season provides the perfect opportunity to give thanks and to give back to youth who are facing challenges within our communities. In days of uncertainty, there are still people who are providing direction and mentoring to high-risk youth to help them succeed in spite of the unfortunate circumstances they may have encountered. Many studies indicate that a young person’s success can be greatly enhanced by an advocate or mentor — an adult who consistently helps a young person stay on track to graduate and make better life choices. Goodwill’s GoodGuides program is the source of many modern-day mentoring success stories.
The GoodGuides program provides mentoring to youth, ages 12–17, who are at risk of dropping out of school and/or falling into delinquency. The program helps them finish school, transition into the world of work and prepare for success by pairing them with trusted adult volunteer mentors. Mentors help youth overcome disadvantages such as failure in school due to poor grades or low attendance, or avoid delinquency due to issues such as abuse, disability, drug or alcohol dependence, family violence or gang membership.
To view the multimedia release go to:
http://www.multivu.com/players/English/7057252-goodwill-givegoodwill-campaign/
In a glittering venue hosted at The Athens Concert Hall on May 15, 2017, attended by State officials and business representatives from all sectors of the economy, Mr. Gabriel Chaleplis was honoured for his international entrepreneurship.
The award to Mr. Gabriel Chaleplis was presented by Mr. Elias Xanthakos, Secretary General of The Greek Ministry of Economy and Development.
The award was presented for the first time in Greece, in order to honour international entrepreneurs of Greek origin who have demonstrated success, ethics, an international mind-set, and major achievements on global level.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8111251-b2b-gaming-gabriel-chaleplis-entrepreneur/
As host of Travel Channel’s popular series “Hotel Impossible,” “hotel fixer” Anthony Melchiorri is relentless when it comes to getting struggling hotels all over the world back on their feet and on the path to success. His no-nonsense approach may put some owners off, but his advice can transform even the most down-and-out properties. Yet it’s ultimately up to the hotel owners to implement and maintain his changes. On “Hotel Impossible Undercover,” a series of six half-hour specials premiering Monday, January 6 at 10:00 p.m. & 10:30 p.m. ET/PT with back-to-back episodes, Melchiorri returns to check up on six properties he previously overhauled on past seasons of “Hotel Impossible.” Following the run of specials, a compelling new fourth season of “Hotel Impossible” premieres on Monday, January 27 at 10:00 p.m. ET/PT. With thirteen hour-long episodes, Melchiorri’s management skills, emotions and patience are put to the test once again.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64287-travel-channels-hotel-impossible-anthony-melchiorri-undercover-specials
Long before it's time for hospice care, many people with serious illness can benefit from palliative care but don’t realize it. Sometimes referred to as “comfort care,” palliative care is a specialized approach to the treatment of patients with a serious or life-threatening illness. Palliative care has helped Deadra Gladden get her life back through symptom management and support from Samaritan Healthcare & Hospice, Marlton, N.J.
In May of 2014 Deadra, age 28, was in the hospital, feeling hopeless and in excruciating pain due to lupus, a disease she has been battling for over half her young life. Deadra's doctors told her family it was time to call hospice. But after consulting with a nurse from Samaritan Healthcare and Hospice, a palliative care team was brought in instead.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today that NFL analyst and philanthropist, Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, will serve as a brand ambassador for BOTOX® Cosmetic.
Harnessing Sanders’ trademark swagger, style and humor, Allergan also released two videos featuring Sanders sharing how he addressed his moderate to severe frown lines and crow’s feet with BOTOX® Cosmetic and showing men everywhere how the treatment may be right for them as well.
To view the multimedia release go to:
https://www.multivu.com/players/English/8174251-allergan-deion-sanders-botox/
When friends and families can't be together at Thanksgiving, celebrating may become a little less joyful. In fact, nearly half of Americans (45 percent) say they would skip certain family traditions if they had to spend Thanksgiving alone, while nearly one in five (19 percent) would skip the holiday entirely. So this Thanksgiving, SC Johnson is launching Happy Thanksgathering™, giving families who might not be together this holiday season the chance to gather, to give thanks and to celebrate.
Now through Wed, Nov. 25, consumers can visit www.HappyThanksgathering.com for daily chances to enter a sweepstakes to win a $1,000 “Help Me Get Home” Visa rewards card to put toward a trip home this holiday season. They also have the option to enter a second sweepstakes for the chance to win a $250 “Help Me Host” gift card to help pay for a holiday feast with loved ones.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7671331-sc-johnson-a-family-company/
If you are short in magnesium, you may not show any symptoms, you may just ignore them, or you may attribute them to some other nutrient deficiency. However, moderate or severe magnesium deficiency results in malnutrition, loss of appetite, nausea, weakness, personality changes, and arrhythmias.
The 2014 model-year vehicles and brands (in both non-luxury and luxury categories) with the lowest projected ownership costs were announced today by Kelley Blue Book www.kbb.com, the leading provider of new and used car information. These awards are based on Kelley Blue Book’s 5-Year Cost to Own data for new cars for the initial five-year ownership period.
While depreciation (or loss of value) and fuel costs may be the greatest expense incurred in owning a vehicle, there are other factors that can have a significant impact on a consumer’s pocketbook. Available on Kelley Blue Book’s KBB.com, 5-Year Cost to Own information takes into consideration depreciation, expected fuel costs, finance and insurance fees, maintenance and repair costs, and state fees for new models.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65344-kelley-blue-book-kbb-announces-2014-5-cost-to-own-award-winners
Clayton, a Berkshire Hathaway company and one of the leading builders of manufactured, modular and site built homes, will feature architect Jeffrey Dungan’s Low Country floorplan from the Designer Series Tiny Homes collection on Saturday, May 6, at CenturyLink Center in Omaha, Neb. during Berkshire Hathaway’s Annual Shareholders Meeting.
This year Berkshire Hathaway shareholders will be invited to tour the Low Country, a Clayton tiny home design from the Designer Series. These small modular homes are built indoors at a Clayton home building facility in Addison, Ala. specifically fitted to build Clayton Tiny Homes. The facility is ISO 14001 registered for green building practices, and the tiny homes are built to the International Residential Code (IRC). This small modular home is designed for permanent living and exemplifies the growing trend toward smarter living spaces with luxury amenities and clever storage solutions.
To view the multimedia release go to:
https://www.multivu.com/players/English/8011653-clayton-tiny-homes-designer-series/
St. Jude Children’s Research Hospital® will celebrate its 14th annual FedEx/St. Jude Angels and Stars Gala, by welcoming back model and television personality, as well as co-founder, Daisy Fuentes, for an evening of fine dining and Latin music at 6:30 p.m. on Saturday, May 14, at the Intercontinental Hotel in downtown Miami. The annual event raises funds to help ensure families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live.
Cuban-born American journalist and one of Time magazine’s “25 Most Influential Hispanics in America,” Cristina Saralegui, will be recognized for her commitment to giving back and educating the Hispanic community. “Being recognized by St. Jude Children’s Research Hospital is a true honor. Lending my voice to matters that touch my heart is what’s it’s all about. These children need our help and they need your help,” said Saralegui.
To view the multimedia release go to:
http://www.multivu.com/players/English/7758751-st-jude-angels-stars-gala/
Eisai Inc. today announced the launch of a new national television advertising campaign for BELVIQ® (lorcaserin HCl) CIV, an FDA-approved prescription therapy for chronic weight management. The advertisement will air on numerous channels including Lifetime, Oxygen and AMC.
The spot illustrates the struggles many people face when they are trying to lose or control their weight. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help some patients lose weight and keep it off.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161051-eisai-launches-national-television-campaign-belviq-lorcaserin-hcl-civ
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
